![Lin Ni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lin Ni
Direktor/Vorstandsmitglied bei
TENNOR THERAPEUTICS (SUZHOU) LIMITED
Profil
Lin Ni is currently the Managing Director at 6 Dimensions Capital since 2017 and an Independent Non-Executive Director at TenNor Therapeutics Suzhou Ltd. starting in 2025.
Former positions include Managing Director at Frontline Bioventures, Director at Shanghai Ark Biopharmaceutical Co., Ltd. in 2021, and Non-Executive Director at Edding Genor Group Holdings Ltd. from 2021 to 2022.
Education includes a doctorate degree from Osaka University conferred in 2009.
Aktive Positionen von Lin Ni
| Unternehmen | Position | Beginn |
|---|---|---|
| TENNOR THERAPEUTICS (SUZHOU) LIMITED | Direktor/Vorstandsmitglied | 08.07.2025 |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Private Equity Investor | 18.05.2017 |
Ehemalige bekannte Positionen von Lin Ni
| Unternehmen | Position | Ende |
|---|---|---|
| EDDING GENOR GROUP HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 29.07.2022 |
Frontline Bioventures
 Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Direktor/Vorstandsmitglied | 18.05.2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in biopharmaceutical services | Direktor/Vorstandsmitglied | - |
Ausbildung von Lin Ni
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Osaka University
 Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in biopharmaceutical services | Health Technology |
TenNor Therapeutics Suzhou Ltd.
 TenNor Therapeutics Suzhou Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which engages in discovery, development and commercialization of therapies for bacterial infections and metabolism | Health Technology |
Genor Biopharma Holdings Ltd.
 Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs | Health Technology |
